OOIR: Observatory of International Research

Papers

(The H4-Index of Medicinal Research Reviews is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
	190
	172
	163
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery	159
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers	151
The role and prospect of lysine‐specific demethylases in cancer chemoresistance	129
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy	119
New drug approvals for 2022: Synthesis and clinical applications	105
Galectin‐8 inhibition and functions in immune response and tumor biology	105
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders	103
Key characters of glycodrugs	86
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment	83
Front Cover Image, Volume 45, Issue 1	78
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel	76
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders	72
Current and emerging approaches to noncompetitive AR inhibition	72
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents	71
A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses	70
Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective	65
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer	64
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review	61
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing	61
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases	60
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators	58
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases	56

Enhancing healthy aging with small molecules: A mitochondrial perspective	53
α‐Synuclein in Parkinson's Disease: From Bench to Bedside	53
Mitochondrial quality control proteases and their modulation for cancer therapy	51
Emerging roles of nerve‐bone axis in modulating skeletal system	42
Issue Information	39
Current nanocomposite advances for biomedical and environmental application diversity	39
Issue Information	38
Human Cyclophilins—An Emerging Class of Drug Targets	37
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis	37
Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer Therapy	37
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds	36